Study on the Effect Fractional Ablative Erbium: YAG Laser in Treatment of Melasma

Abstract

Introduction: Melasma is a kind of acquired chronic hyperpigmentation that primarily have an effect on women on sun-exposed regions of the body, particularly on the face in Fitzpatrick skin types III-V. The investigation background is at the Dermatology Clinic at NILES, Cairo University, Egypt. The aim: This investigation aims to evaluate the clinical value and protection of fractional ablative erbium: YAG Laser therapy in handling the melasma. Patients, materials and methods: This study included 30 patients with melasma on their face aged 20-50 years. The patients were treated by four sessions of fractional erbium YAG laser at a period of four weeks. Results: The percentage of improvement in patients treated by fractional erbium YAG laser was 20 – 80% with a mean 54.33 ± 18.01. Conclusion: It was monitored that fractional erbium YAG is successful in treatment of patients with melasma.